Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
Director departure
Letter to company
Asset disposition
Appointed director
NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/09/2020 GN Navidea Biopharmaceuticals to Present at the Virtual Investor Fireside Chat Series
06/03/2020 GN Navidea Biopharmaceuticals Announces Acceptance of Abstract for Presentation at the European League Against Rheumatism (EULAR) Congress
11/15/2018 GN Recent Analysis Shows Aquantia, Ubiquiti Networks, Reliv' International, Permian Basin Royalty Trust, Patriot Transportation Holding, and Navidea Biopharmaceuticals Market Influences ?? Renewed Outlook, Key Drivers of Growth
05/02/2018 BW Navidea Biopharmaceuticals Schedules First Quarter 2018 Earnings Conference Call and Business Update
04/03/2018 BW Navidea Biopharmaceuticals Schedules Conference Call to Discuss Future Outlook and Outcomes of Court Trial
02/28/2018 BW Navidea Biopharmaceuticals Schedules Fourth Quarter and Full Year 2017 Earnings Conference Call and Business Update
02/01/2018 BW Navidea to Host Moderated Q&A Webcast with Management
11/07/2017 BW Navidea Biopharmaceuticals Reports Third Quarter 2017 Financial Results
10/31/2017 BW Navidea Biopharmaceuticals Schedules Third Quarter 2017 Earnings Conference Call and Business Update
09/08/2017 BW Navidea Biopharmaceuticals to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
08/30/2017 BW Navidea To Initiate Regular Webcast Series Featuring Moderated Q&A with Management
08/08/2017 BW Navidea Biopharmaceuticals Reports Second Quarter 2017 Financial Results
06/01/2017 BW Navidea Biopharmaceuticals to Present at the 7th Annual LD Micro Invitational Investor Conference
05/09/2017 BW Navidea Biopharmaceuticals Reports First Quarter 2017 Financial Results
03/29/2017 BW Navidea Provides Corporate Update and Reports Full Year 2016 Results
08/16/2011 BW Neoprobe Elects Gordon Troup Chairman of the Board
08/15/2011 BW Neoprobe Announces 2011 Annual Meeting Results
07/20/2011 BW Neoprobe Establishes European Business Unit
05/25/2011 BW Neoprobe Announces Sale of Gamma Detection Device Business to Devicor Medical Products
05/09/2011 BW Neoprobe Announces First Quarter 2011 Results
05/09/2011 BW CORRECTING and REPLACING Neoprobe to Present at 10th Annual JMP Securities Research Conference
05/09/2011 BW CORRECTING and REPLACING Neoprobe to Present at 10th Annual JMP Securities Research Conference
05/06/2011 BW Neoprobe 1st Quarter 2011 Earnings Conference Call Invitation
05/03/2011 BW Lymphoseek® (Tilmanocept) Meets All Endpoints in NEO3-09 Phase 3 Study
04/18/2011 BW Neoprobe Reaches Agreement with Platinum on Board Nominations
04/01/2011 BW Neoprobe to Present at Needham and Company's 10th Annual Healthcare Conference
03/30/2011 BW Neoprobe Announces Retirement of David Bupp and Appointment of Mark Pykett as President and CEO Effective April 15th
03/23/2011 BW Neoprobe Shareholder Submits Board Nominations and Files Schedule 13D
03/08/2011 BW LifeSci Advisors Announces Investment Opinion on Neoprobe Corporation
03/07/2011 BW Neoprobe Announces 2010 Results with Record Medical Device Sales
03/03/2011 BW Neoprobe 4th Quarter and Year-End 2010 Earnings Conference Call Invitation
03/03/2011 BW Neoprobe to Present at Cowen and Company 31st Annual Health Care Conference
02/24/2011 PRN Naviscan® Announces Collaboration With Neoprobe Corporation to Enable Pipeline Technology Development
12/09/2010 BW Neoprobe Granted Pre-IND Meeting with FDA to Review RIGS Technology
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy